Drug Insights

Effortless Searching: How to Find Terbinafine on Synapse

29 March 2024
2 min read

Terbinafine, a diminutive molecule that bears immense pharmacological prowess, exhibits its inhibitory functions via the obstruction of SQLE - a pivotal enzyme in the biosynthesis of ergosterol, the cardinal component of fungal cell membranes. As a result of this inhibition, terbinafine assails the fungal cell membrane, prompting a cascade of events that ultimately culminate in the fungus's untimely demise. Terbinafine has been employed in the clinical realm to treat an array of fungal infections, including onychomycosis and tinea cruris. This drug was granted the stamp of approval by the FDA in April of 1998 and was developed by GSK. Click on the image below to begin the exploration journey of Terbinafine through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

FDA Approves Bio-Thera's Phase II Trial of Novel ADC BAT8006
Latest Hotspot
3 min read
FDA Approves Bio-Thera's Phase II Trial of Novel ADC BAT8006
29 March 2024
US FDA grants Bio-Thera Solutions approval to start Phase II trial of BAT8006, a novel ADC aimed at Folate Receptor alpha.
Read →
What is Active Pharmaceutical Ingredient?
"What" Series
2 min read
What is Active Pharmaceutical Ingredient?
29 March 2024
Active Pharmaceutical Ingredient (API) refers to the main substance in a drug that provides the therapeutic effect.
Read →
AbbVie's Acquisition of Landos Biopharma Bolsters Inflammatory and Autoimmune Treatment Portfolio
Latest Hotspot
3 min read
AbbVie's Acquisition of Landos Biopharma Bolsters Inflammatory and Autoimmune Treatment Portfolio
29 March 2024
AbbVie Plans to Take Over Landos Biopharma, Enhancing Its Collection of Treatments for Inflammation and Autoimmunity.
Read →
Making the Most Out of Synapse: Searching for Nystatin
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Nystatin
29 March 2024
Nystatin, a minuscule molecule drug with a penchant for functioning as an ergosterol binder, engages in targeting fungal cells, blocking their growth and replication.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.